首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Pancreatic carcinoma incidence and survival in Sweden in 1980-2000: a population-based study of 16,758 hospitalized patients with special reference to different therapies.
【24h】

Pancreatic carcinoma incidence and survival in Sweden in 1980-2000: a population-based study of 16,758 hospitalized patients with special reference to different therapies.

机译:1980-2000年瑞典的胰腺癌发病率和生存率:一项针对16758名住院患者的人群研究,特别参考了不同的疗法。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIMS: The purpose of this study was to analyze the incidence and survival of pancreatic carcinoma in Sweden during 1980-2000. METHODS: In this population-based study the patients were identified in the Swedish Hospital Discharge Register and Cancer Register. Data were matched with those in the Register of Causes of Death in Sweden, and 16,758 patients were identified. RESULTS: During the studied period, 1819 patients underwent pancreatic resection, 7457 were treated with palliative procedures and, in 7482, no intervention was carried out. The incidence of pancreatic carcinoma in Sweden for men dropped from 16 per 100,000 at the beginning of the period to 8 per 100,000 in the year 2000. Corresponding figures for women were 12 and 7, respectively. Patients who underwent pancreatic resection had significantly longer survival compared to the palliative procedure or no-intervention groups (p<0.001). After 12 months 49.7% of the resected patients were alive while the corresponding survival in the palliative procedure and no-intervention groups were 13.6% and 11.9%, respectively. The five-year survival rate after resection was 10.8%. In the resection group survival improved over time (p<0.001) and women survived longer than men (p<0.01), which was not the case in the palliative procedure or no-intervention groups. CONCLUSIONS: During the study period, the incidence of pancreatic carcinoma in Sweden decreased markedly. The resection rate increased and only in this group of patients an improved survival was noted over time. The survival was the same for patients who underwent palliative interventions as for those who only received supportive care.
机译:目的:本研究的目的是分析1980-2000年瑞典胰腺癌的发生率和生存率。方法:在这项基于人群的研究中,在瑞典医院出院登记册和癌症登记册中确定了患者。数据与瑞典的死亡原因登记册中的数据相匹配,确定了16,758例患者。结果:在研究期间,对1819例行胰腺切除术的患者进行了7457例姑息治疗,而在7482例中未进行任何干预。瑞典男性胰腺癌的发病率从初期的每100,000人中的16例下降到2000年的每100,000人中的8例。女性的相应数字分别为12和7。与姑息性手术或无干预组相比,接受胰腺切除术的患者的生存期显着更长(p <0.001)。 12个月后,有49.7%的切除患者还活着,而姑息治疗组和无干预组的相应存活率分别为13.6%和11.9%。切除后的五年生存率为10.8%。在切除组中,随着时间的推移,生存率提高了(p <0.001),女性的生存时间比男性长(p <0.01),而姑息治疗组或无干预组则没有。结论:在研究期间,瑞典胰腺癌的发生率明显下降。随着时间的推移,切除率增加,并且仅在该组患者中观察到生存改善。接受姑息治疗的患者与仅接受支持治疗的患者的生存率相同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号